Preliminary Results of a Combined Score Based on sIL2-Rα and TIM-3 Levels Assayed Early After Hematopoietic Transplantation-Reference-Cited by-同舟云学术

Preliminary Results of a Combined Score Based on sIL2-Rα and TIM-3 Levels Assayed Early After Hematopoietic Transplantation

Published:2020-02-07 Issue: Volume:10 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Leotta Salvatore,Sapienza Giuseppe,Camuglia Maria Grazia,Avola Giuseppe,Marco Annalia Di,Moschetti Gaetano,Curto Pelle Angelo,Markovic Uros,Milone Giulio Antonio,Cupri Alessandra,Bianco Oriana,Frontini Viviana,Spadaro Andre,Marchese Anna Elisa,Crocchiolo Roberto,Milone Giuseppe

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference27 articles.

1. Reduced mortality after allogeneic hematopoietic cell transplantation;Gooley;N Engl J Med,2010

2. Implications of TNF-alpha in the pathogenesis and management of GVHD. Int;Levine;J. Hematol,2011

3. Biomarkers for post-transplantation outcomes;Paczesny;Blood,2018

4. ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death;Vander Lugt;N Engl J Med,2013

5. High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation;Ponce;Blood,2015

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unravelling the potential of TIM-3 gene polymorphism in allogeneic hematopoietic stem cell transplantation - a preliminary study;Transplant Immunology;2024-08

2. Hematopoietic Stem Cells and Their Niche in Bone Marrow;International Journal of Molecular Sciences;2024-06-21

3. Acute GVHD classification based on the dynamics of GVHD skin involvement from its appearance to the start of systemic treatment;Bone Marrow Transplantation;2023-09-25

4. “Grade-1 Skin-only Acute-gvhd”: One Week After Rash Appearance as the Time Point to Decide on Treatment;2023-04-28

5. Soluble TIM-3 as a biomarker of progression and therapeutic response in cancers and other of human diseases;Biochemical Pharmacology;2023-03